159 related articles for article (PubMed ID: 17823445)
1. Influence of inulin on plasma isoflavone concentrations in healthy postmenopausal women.
Piazza C; Privitera MG; Melilli B; Incognito T; Marano MR; Leggio GM; Roxas MA; Drago F
Am J Clin Nutr; 2007 Sep; 86(3):775-80. PubMed ID: 17823445
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women.
Zubik L; Meydani M
Am J Clin Nutr; 2003 Jun; 77(6):1459-65. PubMed ID: 12791624
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women.
Anupongsanugool E; Teekachunhatean S; Rojanasthien N; Pongsatha S; Sangdee C
BMC Clin Pharmacol; 2005 Mar; 5():2. PubMed ID: 15743537
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako).
Watanabe S; Yamaguchi M; Sobue T; Takahashi T; Miura T; Arai Y; Mazur W; Wähälä K; Adlercreutz H
J Nutr; 1998 Oct; 128(10):1710-5. PubMed ID: 9772140
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes.
Setchell KD; Brown NM; Desai PB; Zimmer-Nechimias L; Wolfe B; Jakate AS; Creutzinger V; Heubi JE
J Nutr; 2003 Apr; 133(4):1027-35. PubMed ID: 12672914
[TBL] [Abstract][Full Text] [Related]
6. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.
Védrine N; Mathey J; Morand C; Brandolini M; Davicco MJ; Guy L; Rémésy C; Coxam V; Manach C
Eur J Clin Nutr; 2006 Sep; 60(9):1039-45. PubMed ID: 16482068
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of a slow-release formulation of soybean isoflavones in healthy postmenopausal women.
Setchell KD; Brzezinski A; Brown NM; Desai PB; Melhem M; Meredith T; Zimmer-Nechimias L; Wolfe B; Cohen Y; Blatt Y
J Agric Food Chem; 2005 Mar; 53(6):1938-44. PubMed ID: 15769117
[TBL] [Abstract][Full Text] [Related]
8. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women.
Xu X; Wang HJ; Murphy PA; Cook L; Hendrich S
J Nutr; 1994 Jun; 124(6):825-32. PubMed ID: 8207540
[TBL] [Abstract][Full Text] [Related]
9. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women.
Bloedon LT; Jeffcoat AR; Lopaczynski W; Schell MJ; Black TM; Dix KJ; Thomas BF; Albright C; Busby MG; Crowell JA; Zeisel SH
Am J Clin Nutr; 2002 Nov; 76(5):1126-37. PubMed ID: 12399289
[TBL] [Abstract][Full Text] [Related]
10. Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity.
Zhang Y; Wang GJ; Song TT; Murphy PA; Hendrich S
J Nutr; 1999 May; 129(5):957-62. PubMed ID: 10222386
[TBL] [Abstract][Full Text] [Related]
11. Effect of synbiotic fermented milk on oral bioavailability of isoflavones in postmenopausal women.
Timan P; Rojanasthien N; Manorot M; Sangdee C; Teekachunhatean S
Int J Food Sci Nutr; 2014 Sep; 65(6):761-7. PubMed ID: 24720601
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the soybean isoflavone daidzein in its aglycone and glucoside form: a randomized, double-blind, crossover study.
Rüfer CE; Bub A; Möseneder J; Winterhalter P; Stürtz M; Kulling SE
Am J Clin Nutr; 2008 May; 87(5):1314-23. PubMed ID: 18469255
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of soybean isoflavones depends upon gut microflora in women.
Xu X; Harris KS; Wang HJ; Murphy PA; Hendrich S
J Nutr; 1995 Sep; 125(9):2307-15. PubMed ID: 7666247
[TBL] [Abstract][Full Text] [Related]
14. Rapid gut transit time and slow fecal isoflavone disappearance phenotype are associated with greater genistein bioavailability in women.
Zheng Y; Hu J; Murphy PA; Alekel DL; Franke WD; Hendrich S
J Nutr; 2003 Oct; 133(10):3110-6. PubMed ID: 14519793
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.
Setchell KD; Brown NM; Desai P; Zimmer-Nechemias L; Wolfe BE; Brashear WT; Kirschner AS; Cassidy A; Heubi JE
J Nutr; 2001 Apr; 131(4 Suppl):1362S-75S. PubMed ID: 11285356
[TBL] [Abstract][Full Text] [Related]
16. Hydrolysis of isoflavone glycosides to aglycones by beta-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women.
Richelle M; Pridmore-Merten S; Bodenstab S; Enslen M; Offord EA
J Nutr; 2002 Sep; 132(9):2587-92. PubMed ID: 12221213
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage.
Shelnutt SR; Cimino CO; Wiggins PA; Ronis MJ; Badger TM
Am J Clin Nutr; 2002 Sep; 76(3):588-94. PubMed ID: 12198004
[TBL] [Abstract][Full Text] [Related]
18. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans.
King RA; Bursill DB
Am J Clin Nutr; 1998 May; 67(5):867-72. PubMed ID: 9583843
[TBL] [Abstract][Full Text] [Related]
19. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women.
Setchell KD; Faughnan MS; Avades T; Zimmer-Nechemias L; Brown NM; Wolfe BE; Brashear WT; Desai P; Oldfield MF; Botting NP; Cassidy A
Am J Clin Nutr; 2003 Feb; 77(2):411-9. PubMed ID: 12540402
[TBL] [Abstract][Full Text] [Related]
20. Large inter-individual variation in isoflavone plasma concentration limits use of isoflavone intake data for risk assessment.
van der Velpen V; Hollman PC; van Nielen M; Schouten EG; Mensink M; Van't Veer P; Geelen A
Eur J Clin Nutr; 2014 Oct; 68(10):1141-7. PubMed ID: 24939433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
